ViaLase CEO talks innovations in glaucoma treatment

Tibor Juhasz, CEO of ViaLase, Inc, discusses the company's development of a novel, noninvasive high-resolution OCT image-guided femtosecond laser technology for the treatment of open-angle glaucoma.

Related Videos

Related Content

Advertisement

November 19th 2024

SpyGlass Pharma completes enrollment in Phase I/II study of its long-term drug delivery platform for glaucoma and ocular hypertension

November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

November 18th 2024

Long-term blood pressure variability and visual field progression in glaucoma

November 5th 2024

Innovation Series: Putting the buzz of large language models in ophthalmology into perspective with Robert T. Chang, MD

November 11th 2024

Noninvasive choroidal vessel analysis using deep learning: A novel approach to OCT angiography

November 1st 2024

AAO 2024: Ocular imaging in the emergency department can provide timely, accurate diagnosis

Related Content

Advertisement

November 19th 2024

SpyGlass Pharma completes enrollment in Phase I/II study of its long-term drug delivery platform for glaucoma and ocular hypertension

November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

November 18th 2024

Long-term blood pressure variability and visual field progression in glaucoma

November 5th 2024

Innovation Series: Putting the buzz of large language models in ophthalmology into perspective with Robert T. Chang, MD

November 11th 2024

Noninvasive choroidal vessel analysis using deep learning: A novel approach to OCT angiography

November 1st 2024

AAO 2024: Ocular imaging in the emergency department can provide timely, accurate diagnosis